Home/Anwita Biosciences/Eugene Liu, M.D. Ph.D.
EL

Eugene Liu, M.D. Ph.D.

Chief Medical Officer

Anwita Biosciences

Anwita Biosciences Pipeline

DrugIndicationPhase
AWT020NSCLC, GI and gynecological cancersPhase 1
AWT026Melanoma (combo with aPD-1; CAR-T)Preclinical
JS212NSCLC; CRCLead Optimization
AWT041Solid tumorsIND Enabling
AWT032Hematological autoimmune diseaseLead ID
AWT038Cancer Cachexia (Solid tumors)Preclinical